The June Hot Topics focuses on the challenges venetoclax regimens have faced in multiple myeloma trials.
Zachary M. Avigan, MD
Advertisement
Articles by Zachary M. Avigan, MD
Advertisement
Latest Updated Articles
Continued Success of Venetoclax in t(11;14) Multiple Myeloma Despite Negative TrialsPublished: June 14th 2024 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ASH 2025: Key Anticipated Updates in the Leukemia Landscape
2
Fixed-Duration Venetoclax Combos Show Noninferior PFS to Ibrutinib in CLL
3
Real-World Elranatamab Maintains Responses in Elderly, Frail R/R Multiple Myeloma
4
Survival Benefit Seen With Cilta-Cel in Earlier Lines of Myeloma Treatment
5
